188 related articles for article (PubMed ID: 4034582)
1. Combination of hormonal and cytostatic treatment for advanced carcinoma of the prostate.
Servadio C
Prog Clin Biol Res; 1985; 185A():407-26. PubMed ID: 4034582
[No Abstract] [Full Text] [Related]
2. The questionable use of hormone therapy in advanced carcinoma of the prostate.
Murphy GP; Slack NH
Urol Clin North Am; 1980 Oct; 7(3):631-8. PubMed ID: 6161459
[No Abstract] [Full Text] [Related]
3. Management of metastatic prostatic cancer.
Paulson DF
Urology; 1985 Feb; 25(2 Suppl):49-52. PubMed ID: 3918376
[TBL] [Abstract][Full Text] [Related]
4. The EORTC Phase III trials in prostatic cancer.
Robinson MR; Smith PH; Macaluso MP; Sylvester R; de Voogt H
Prog Clin Biol Res; 1985; 185A():243-9. PubMed ID: 3898132
[No Abstract] [Full Text] [Related]
5. Hormonal therapy for prostate cancer.
Torti FM
N Engl J Med; 1984 Nov; 311(20):1313-4. PubMed ID: 6436701
[No Abstract] [Full Text] [Related]
6. Lessons from phase III-trials on the hormonal treatment of prostatic cancer. I: Results of EORTC-trials 30761 and 30762.
de Voogt HJ; Pavone-Macaluso M; Smith PH; de Pauw M; Suciu S
Prog Clin Biol Res; 1988; 260():111-7. PubMed ID: 2966403
[No Abstract] [Full Text] [Related]
7. [Advanced prostatic cancer: therapeutic modalities].
Faul P; Altwein JE
Dtsch Med Wochenschr; 1984 Dec; 109(51-52):1975-80. PubMed ID: 6391887
[No Abstract] [Full Text] [Related]
8. Management of newly diagnosed metastatic carcinoma of the prostate.
Elder JS; Catalona WJ
Urol Clin North Am; 1984 May; 11(2):283-95. PubMed ID: 6428022
[TBL] [Abstract][Full Text] [Related]
9. [Current aspects of hormonal therapy in prostate cancer].
Altwein JE
Helv Chir Acta; 1981 Aug; 48(3-4):391-5. PubMed ID: 7287476
[TBL] [Abstract][Full Text] [Related]
10. [Drug therapy of metastasizing prostate carcinoma with special reference to the bioavailability of fosfestrol after oral administration].
Oelschläger H; Rothley D; Dunzendorfer U
Arzneimittelforschung; 1988 Oct; 38(10):1502-12. PubMed ID: 3058134
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostics and therapy of the carcinoma of the prostate (author's transl)].
Schnorr D; Guddat HM; Neuser D; Correns HJ; Dörner G; Mau S
Zentralbl Chir; 1979; 104(7):436-45. PubMed ID: 112805
[TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy of advanced prostate cancer].
Murphy GP
Vopr Onkol; 1977; 23(12):26-38. PubMed ID: 146305
[No Abstract] [Full Text] [Related]
13. Preoperative endocrine therapy in patients with locally advanced prostate cancer.
Maeda O; Meguro N; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
Jpn J Clin Oncol; 1995 Aug; 25(4):135-9. PubMed ID: 7545250
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of aminoglutethimide in stage D prostate cancer: an assessment of efficacy and toxicity in patients with tumors refractory to hormonal therapy.
Block M; Trump D; Rose DP; Cummings KB; Hogan TF
Cancer Treat Rep; 1984 May; 68(5):719-22. PubMed ID: 6722829
[No Abstract] [Full Text] [Related]
15. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
Nickel CJ; Morales A
Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988
[TBL] [Abstract][Full Text] [Related]
16. [Cellular immunity in prostatic cancer modified by Cytonal, Estrazyt and Turisteron].
Klebingat KJ; Panzig E; Lorenz G; Steinhauser I; Fiedler R
Z Urol Nephrol; 1987 Mar; 80(3):139-47. PubMed ID: 3300097
[TBL] [Abstract][Full Text] [Related]
17. Androgen depletion/repletion in combination with chemotherapy: strategy for secondary treatment of metastatic prostatic cancer.
Santen RJ; English H; Rohner T; Drago J; Lipton A; Harvey H; Simmonds M; Boucher A; Glode LM; Wettlaufer J
Prog Clin Biol Res; 1985; 185A():359-71. PubMed ID: 4034580
[No Abstract] [Full Text] [Related]
18. Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases.
Koutsilieris M; Mitsiades CS; Bogdanos J; Dimopoulos T; Karamanolakis D; Milathianakis C; Tsintavis A
Clin Cancer Res; 2004 Jul; 10(13):4398-405. PubMed ID: 15240528
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy programs of the National Prostatic Cancer Project (NPCP).
Schmidt JD; Scott WW; Gibbons R; Johnson DE; Prout GR; Loening S; Soloway M; deKernion JB; Pontes JE; Slack NH; Murphy GP
Cancer; 1980 Apr; 45(7 Suppl):1937-46. PubMed ID: 6445225
[No Abstract] [Full Text] [Related]
20. The treatment of hormone refractory prostate cancer.
Panvichian R; Pienta KJ
Compr Ther; 1996 Feb; 22(2):81-7. PubMed ID: 8689867
[No Abstract] [Full Text] [Related]
[Next] [New Search]
